Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed‐dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator‐blind, parallel‐group study

Adapalene 0.1% (ADA) with clindamycin phosphate 1.2% (CLNP; ADA + CLNP) and the fixed‐dose combination containing CLNP and benzoyl peroxide 3% (CLNP/BPO 3%) are strongly recommended for the early treatment of acne vulgaris in Japan. Here, we compare the early efficacy and safety of CLNP/BPO 3% with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Nobukazu, Kurokawa, Ichiro, Siakpere, Obukohwo, Endo, Akira, Hatanaka, Toshiki, Yamada, Masahiro, Kawashima, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099304/
https://www.ncbi.nlm.nih.gov/pubmed/29905384
http://dx.doi.org/10.1111/1346-8138.14497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099304/
https://www.ncbi.nlm.nih.gov/pubmed/29905384
http://dx.doi.org/10.1111/1346-8138.14497

Ejemplares similares